Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 10, 2025 Filed Dec 11, 2025 22:44 UTC |
Pauls MatthewDirector · CHIEF EXECUTIVE OFFICER
|
GiftCommon Stock | 23,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-316295 · ownership.xml · nonDerivative · entry 1 Pauls Matthew · CIK 0001573429 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,512,750 F1 · shares: The reporting person made a bona fide gift to The Pennington School. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 22:50 UTC |
Hawkins Richard JDirector
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-316315 · ownership.xml · nonDerivative · entry 1 Hawkins Richard J · CIK 0001307632 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,326 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 9, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The reporting person has elected to defer receipt of the shares of common stock underlying the RSUs upon vesting. In accordance with the reporting person's deferral election, the vested shares will be delivered to the reporting person following the reporting person's termination of service with the Issuer. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 22:48 UTC |
van Es-Johansson AnDirector
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-316307 · ownership.xml · nonDerivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,500 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 9, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 22:46 UTC |
Elam Nevan CDirector
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-316302 · ownership.xml · nonDerivative · entry 1 Elam Nevan C · CIK 0001314773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,887 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 9, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The reporting person has elected to defer receipt of the shares of common stock underlying the RSUs upon vesting. In accordance with the reporting person's deferral election, the vested shares will be delivered to the reporting person following the reporting person's termination of service with the Issuer. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 22:45 UTC |
RAMSAY DAVID ADirector
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-316299 · ownership.xml · nonDerivative · entry 1 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,553,642 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 9, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 22:45 UTC |
McCracken Joseph SDirector
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-316296 · ownership.xml · nonDerivative · entry 1 McCracken Joseph S · CIK 0001632454 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,837 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 9, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The reporting person has elected to defer receipt of the shares of common stock underlying the RSUs upon vesting. In accordance with the reporting person's deferral election, the vested shares will be delivered to the reporting person following the reporting person's termination of service with the Issuer. Read SEC document |
| December 04, 2025 Filed Dec 4, 2025 23:57 UTC |
Wasfi YasmineChief Medical Officer
|
Tax withholdingCommon Stock | 21,992 | $6.37 | $140,089.04 |
DisclosureSEC source: 0001193125-25-308325 · ownership.xml · nonDerivative · entry 1 Wasfi Yasmine · CIK 0002092127 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,008 F1 · shares: Represents shares withheld by the Issuer in connection with the reporting person's net share settlement to satisfy tax liability based upon the vesting of previously awarded restricted stock units. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 23:55 UTC |
Elam Nevan CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,860 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001193125-25-308324 · ownership.xml · derivative · entry 3 Elam Nevan C · CIK 0001314773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,860 shares Expires 2025-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 15, 2016. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 23:55 UTC |
Elam Nevan CDirector
|
Tax withholdingCommon Stock | 1,473 | $5.81 | $8,558.13 |
DisclosureSEC source: 0001193125-25-308324 · ownership.xml · nonDerivative · entry 2 Elam Nevan C · CIK 0001314773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,887 Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 23:55 UTC |
Elam Nevan CDirector
|
Exercise / conversionCommon Stock | 5,860 | $1.46 | $8,555.60 |
DisclosureSEC source: 0001193125-25-308324 · ownership.xml · nonDerivative · entry 1 Elam Nevan C · CIK 0001314773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,360 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2025 Filed Nov 17, 2025 21:38 UTC |
Hawkins Richard JDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,860 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001193125-25-284702 · ownership.xml · derivative · entry 2 Hawkins Richard J · CIK 0001307632 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,860 shares Expires 2025-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 15, 2016. Read SEC document |
| November 14, 2025 Filed Nov 17, 2025 21:38 UTC |
Hawkins Richard JDirector
|
Exercise / conversionCommon Stock | 5,860 | $1.46 | $8,555.60 |
DisclosureSEC source: 0001193125-25-284702 · ownership.xml · nonDerivative · entry 1 Hawkins Richard J · CIK 0001307632 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 20, 2025 Filed Oct 23, 2025 00:47 UTC |
Wasfi YasmineChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $4.11 | $0.00 |
DisclosureSEC source: 0002092127-25-000004 · ownership.xml · derivative · entry 2 Wasfi Yasmine · CIK 0002092127 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2035-10-20 F2 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of October 17, 2025, subject to the reporting person's continued service with the Issuer. Read SEC document |
| October 20, 2025 Filed Oct 23, 2025 00:47 UTC |
Wasfi YasmineChief Medical Officer
|
GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002092127-25-000004 · ownership.xml · nonDerivative · entry 1 Wasfi Yasmine · CIK 0002092127 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,000 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on October 17, 2027, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 20, 2025 Filed Jun 23, 2025 18:39 UTC |
Hawkins Richard JDirector
|
PurchaseCommon Stock | 48,225 | $2.04 | $98,571.90 |
DisclosureSEC source: 0000950170-25-088895 · ownership.xml · nonDerivative · entry 1 Hawkins Richard J · CIK 0001307632 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,466 F1 · price: The price is a weighted average purchase price. The purchase prices ranged from $2.0345 to $2.045. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 11:59 UTC |
McCracken Joseph SDirector
|
PurchaseCommon Stock | 10,000 | $2.08 | $20,825.00 |
DisclosureSEC source: 0000950170-25-080021 · ownership.xml · nonDerivative · entry 1 McCracken Joseph S · CIK 0001632454 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,837 F1 · price: The price is a weighted average purchase price. The purchase prices ranged from $2.08 to $2.085. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 11:00 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 150,000 | $2.78 | $416,250.00 |
DisclosureSEC source: 0000950170-25-048032 · ownership.xml · nonDerivative · entry 1 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,513,642 F1 · price: The price is a weighted average purchase price. The purchase prices ranged from $2.75 to $2.80. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 21:35 UTC |
Lutz Robert MatthewChief Operating Officer
|
Tax withholdingCommon Stock | 38,263 | $2.83 | $108,284.29 |
DisclosureSEC source: 0000950170-25-021312 · ownership.xml · nonDerivative · entry 1 Lutz Robert Matthew · CIK 0001786203 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 361,737 F1 · shares: Represents shares withheld by the Issuer in connection with the reporting person's net share settlement to satisfy tax liability based upon the vesting of previously awarded restricted stock units. Read SEC document |
| December 16, 2024 Filed Dec 16, 2024 22:59 UTC |
Lowrance David LChief Financial Officer
|
SaleCommon Stock | 25,000 | $3.33 | $83,277.50 |
DisclosureSEC source: 0000950170-24-136785 · ownership.xml · nonDerivative · entry 4 Lowrance David L · CIK 0001408498 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 381,005 F4 · shares: Represents shares sold to satisfy tax liability upon the vesting of restricted stock units. F5 · price: The price is a weighted average sales price. The sale prices ranged from $3.29 to $3.36. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 16, 2024 Filed Dec 16, 2024 22:56 UTC |
Pauls MatthewDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 54,702 | $3.31 | $180,828.40 |
DisclosureSEC source: 0000950170-24-136782 · ownership.xml · nonDerivative · entry 3 Pauls Matthew · CIK 0001573429 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,536,379 F2 · shares: Represents shares sold to satisfy tax liability upon the vesting of restricted stock units. F3 · price: The price is a weighted average sales price. The sale prices ranged from $3.28 to $3.34. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 16, 2024 Filed Dec 16, 2024 22:53 UTC |
Hawkins Richard JDirector
|
SaleCommon Stock | 8,000 | $3.32 | $26,568.80 |
DisclosureSEC source: 0000950170-24-136780 · ownership.xml · nonDerivative · entry 2 Hawkins Richard J · CIK 0001307632 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,241 F2 · shares: Represents shares sold to satisfy tax liability upon the vesting of restricted stock units. F3 · price: The price is a weighted average sales price. The sale prices ranged from $3.29 to $3.36. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 13, 2024 Filed Dec 16, 2024 23:10 UTC |
Erickson AnneChief Business Officer
|
Tax withholdingCommon Stock | 18,263 | $3.21 | $58,624.23 |
DisclosureSEC source: 0000950170-24-136798 · ownership.xml · nonDerivative · entry 2 Erickson Anne · CIK 0002016865 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 434,672 F2 · shares: Represents shares withheld by the Issuer in connection with the reporting person's net share settlement to satisfy tax liability based upon the vesting of previously awarded restricted stock units. Read SEC document |
| December 13, 2024 Filed Dec 16, 2024 22:59 UTC |
Lowrance David LChief Financial Officer
|
Tax withholdingCommon Stock | 24,350 | $3.21 | $78,163.50 |
DisclosureSEC source: 0000950170-24-136785 · ownership.xml · nonDerivative · entry 3 Lowrance David L · CIK 0001408498 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 406,005 F3 · shares: Represents shares withheld by the Issuer in connection with the reporting person's net share settlement to satisfy tax liability based upon the vesting of previously awarded restricted stock units. Read SEC document |
| December 13, 2024 Filed Dec 16, 2024 22:59 UTC |
Lowrance David LChief Financial Officer
|
GiftCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-136785 · ownership.xml · nonDerivative · entry 2 Lowrance David L · CIK 0001408498 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430,355 F2 · shares: The reporting person made a bona fide gift to The McCallie School. The reporting person does not have voting or investment power with respect to the shares held by The McCallie School. Read SEC document |
| December 13, 2024 Filed Dec 16, 2024 22:56 UTC |
Pauls MatthewDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 92,593 | $3.21 | $297,223.53 |
DisclosureSEC source: 0000950170-24-136782 · ownership.xml · nonDerivative · entry 2 Pauls Matthew · CIK 0001573429 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,591,081 Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 23:10 UTC |
Erickson AnneChief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $3.35 | $0.00 |
DisclosureSEC source: 0000950170-24-136798 · ownership.xml · derivative · entry 3 Erickson Anne · CIK 0002016865 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2034-12-12 F3 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 12, 2024, subject to the reporting person's continued service with the Issuer. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 23:10 UTC |
Erickson AnneChief Business Officer
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-136798 · ownership.xml · nonDerivative · entry 1 Erickson Anne · CIK 0002016865 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 452,935 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 12, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 23:07 UTC |
Parker Braden C.Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $3.35 | $0.00 |
DisclosureSEC source: 0000950170-24-136794 · ownership.xml · derivative · entry 2 Parker Braden C. · CIK 0002038915 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2034-12-12 F2 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 12, 2024, subject to the reporting person's continued service with the Issuer. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 23:07 UTC |
Parker Braden C.Chief Commercial Officer
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-136794 · ownership.xml · nonDerivative · entry 1 Parker Braden C. · CIK 0002038915 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,000 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 12, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 23:05 UTC |
Lutz Robert MatthewChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $3.35 | $0.00 |
DisclosureSEC source: 0000950170-24-136790 · ownership.xml · derivative · entry 2 Lutz Robert Matthew · CIK 0001786203 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2034-12-12 F2 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 12, 2024, subject to the reporting person's continued service with the Issuer. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 23:05 UTC |
Lutz Robert MatthewChief Operating Officer
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-136790 · ownership.xml · nonDerivative · entry 1 Lutz Robert Matthew · CIK 0001786203 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 12, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 22:59 UTC |
Lowrance David LChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $3.35 | $0.00 |
DisclosureSEC source: 0000950170-24-136785 · ownership.xml · derivative · entry 5 Lowrance David L · CIK 0001408498 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2034-12-12 F6 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 12, 2024, subject to the reporting person's continued service with the Issuer. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 22:59 UTC |
Lowrance David LChief Financial Officer
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-136785 · ownership.xml · nonDerivative · entry 1 Lowrance David L · CIK 0001408498 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 442,355 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 12, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 22:57 UTC |
Pratt Raymond DennisChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 280,000 | $0.00 Strike: $3.35 | $0.00 |
DisclosureSEC source: 0000950170-24-136783 · ownership.xml · derivative · entry 2 Pratt Raymond Dennis · CIK 0001548356 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,000 Underlying: Common Stock · 280,000 shares Expires 2034-12-12 F2 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 12, 2024, subject to the reporting person's continued service with the Issuer. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 22:57 UTC |
Pratt Raymond DennisChief Medical Officer
|
GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-136783 · ownership.xml · nonDerivative · entry 1 Pratt Raymond Dennis · CIK 0001548356 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340,050 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 12, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 22:56 UTC |
Pauls MatthewDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 900,000 | $0.00 Strike: $3.35 | $0.00 |
DisclosureSEC source: 0000950170-24-136782 · ownership.xml · derivative · entry 4 Pauls Matthew · CIK 0001573429 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 900,000 Underlying: Common Stock · 900,000 shares Expires 2034-12-12 F4 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 12, 2024, subject to the reporting person's continued service with the Issuer. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 22:56 UTC |
Pauls MatthewDirector · CHIEF EXECUTIVE OFFICER
|
GrantCommon Stock | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-136782 · ownership.xml · nonDerivative · entry 1 Pauls Matthew · CIK 0001573429 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,683,674 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 12, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 22:50 UTC |
Elam Nevan CDirector
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-136778 · ownership.xml · nonDerivative · entry 1 Elam Nevan C · CIK 0001314773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 12, 2025, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The reporting person has elected to defer receipt of the shares of common stock underlying the RSUs upon vesting. In accordance with the reporting person's deferral election, the vested shares will be delivered to the reporting person following the reporting person's termination of service with the Issuer. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 22:53 UTC |
Hawkins Richard JDirector
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-136780 · ownership.xml · nonDerivative · entry 1 Hawkins Richard J · CIK 0001307632 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,241 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 12, 2025, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The reporting person has elected to defer receipt of the shares of common stock underlying the RSUs upon vesting. In accordance with the reporting person's deferral election, the vested shares will be delivered to the reporting person following the reporting person's termination of service with the Issuer. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 22:47 UTC |
van Es-Johansson AnDirector
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-136773 · ownership.xml · nonDerivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 12, 2025, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The reporting person has elected to defer receipt of the shares of common stock underlying the RSUs upon vesting. In accordance with the reporting person's deferral election, the vested shares will be delivered to the reporting person following the reporting person's termination of service with the Issuer. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 22:44 UTC |
McCracken Joseph SDirector
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-136770 · ownership.xml · nonDerivative · entry 1 McCracken Joseph S · CIK 0001632454 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,837 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 12, 2025, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The reporting person has elected to defer receipt of the shares of common stock underlying the RSUs upon vesting. In accordance with the reporting person's deferral election, the vested shares will be delivered to the reporting person following the reporting person's termination of service with the Issuer. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 22:40 UTC |
RAMSAY DAVID ADirector
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-136768 · ownership.xml · nonDerivative · entry 1 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,363,642 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 12, 2025, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 19, 2024 Filed Nov 20, 2024 12:55 UTC |
McCracken Joseph SDirector
|
PurchaseCommon Stock | 20,000 | $2.95 | $59,072.00 |
DisclosureSEC source: 0000950170-24-129007 · ownership.xml · nonDerivative · entry 1 McCracken Joseph S · CIK 0001632454 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,837 F1 · price: The price is a weighted average purchase price. The purchase prices ranged from $2.9481 to $2.9678. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| November 18, 2024 Filed Nov 18, 2024 17:33 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 100,000 | $2.88 | $287,600.00 |
DisclosureSEC source: 0000950170-24-127869 · ownership.xml · nonDerivative · entry 1 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,323,642 F1 · price: The price is a weighted average purchase price. The purchase prices ranged from $2.85 to $2.91. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| November 10, 2024 Filed Nov 12, 2024 22:17 UTC |
Pratt Raymond DennisChief Medical Officer
|
Tax withholdingCommon Stock | 49,950 | $3.97 | $198,301.50 |
DisclosureSEC source: 0000950170-24-125681 · ownership.xml · nonDerivative · entry 1 Pratt Raymond Dennis · CIK 0001548356 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,050 F1 · shares: Represents shares withheld by the Issuer in connection with the reporting person's net share settlement to satisfy tax liability based upon the vesting of previously awarded restricted stock units. Read SEC document |
| October 21, 2024 Filed Oct 22, 2024 20:10 UTC |
Erickson AnneChief Business Officer
|
Tax withholdingCommon Stock | 381 | $3.57 | $1,360.17 |
DisclosureSEC source: 0000950170-24-116256 · ownership.xml · nonDerivative · entry 1 Erickson Anne · CIK 0002016865 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 352,935 F1 · shares: Represents shares withheld by the Issuer in connection with the reporting person's net share settlement to satisfy tax liability based upon the vesting of previously awarded restricted stock units. Read SEC document |
| September 25, 2024 Filed Sep 27, 2024 20:35 UTC |
Parker Braden C.Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 170,000 | $0.00 Strike: $4.15 | $0.00 |
DisclosureSEC source: 0000950170-24-110048 · ownership.xml · derivative · entry 2 Parker Braden C. · CIK 0002038915 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,000 Underlying: Common Stock · 170,000 shares Expires 2034-09-25 F2 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of September 24, 2024, subject to the reporting person's continued service with the Issuer. Read SEC document |
| September 25, 2024 Filed Sep 27, 2024 20:35 UTC |
Parker Braden C.Chief Commercial Officer
|
GrantCommon Stock | 85,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-110048 · ownership.xml · nonDerivative · entry 1 Parker Braden C. · CIK 0002038915 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,000 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on September 24, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 21, 2024 Filed Jul 22, 2024 20:16 UTC |
Erickson AnneChief Business Officer
|
Tax withholdingCommon Stock | 381 | $4.47 | $1,703.07 |
DisclosureSEC source: 0000950170-24-085260 · ownership.xml · nonDerivative · entry 1 Erickson Anne · CIK 0002016865 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 353,316 F1 · shares: Represents shares withheld by the Issuer in connection with the reporting person's net share settlement to satisfy tax liability based upon the vesting of previously awarded restricted stock units. Read SEC document |
| April 21, 2024 Filed Apr 23, 2024 20:06 UTC |
Erickson AnneChief Business Officer
|
Tax withholdingCommon Stock | 381 | $4.81 | $1,832.61 |
DisclosureSEC source: 0000950170-24-046888 · ownership.xml · nonDerivative · entry 1 Erickson Anne · CIK 0002016865 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 353,697 F1 · shares: Represents shares withheld by the Issuer in connection with the reporting person's net share settlement to satisfy tax liability based upon the vesting of previously awarded restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.